Pancreatic Cancer Research

ResearcherYokohama City University HospitalActive in the last 2 years

Kensuke Kubota

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6767-0410; OpenAlex author ID A5042269542. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
50
Papers, trials and grants by year

2011: 3 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 13

  1. Enhancing the Diagnostic Performance of Repeated Endoscopic Ultrasound-Guided Tissue Acquisition Combined with Surrogate Repeated Endoscopic Retrograde Pancrea… Co-author DOI 10.1007/s10620-025-09373-5↗
  2. Treatment of initially unresectable local advanced pancreatic adenocarcinoma with FOLFIRINOX: A prospective study YCOG1403 (C-FLAP study). Co-author DOI 10.1038/s41598-025-23608-5↗
  3. Prospective, multicentre trial on preoperative biliary drainage by endoscopic ultrasound-guided hepaticogastrostomy for resectable/borderline resectable pancre… Co-author DOI 10.1136/bmjopen-2025-106543↗
  4. Diagnostic Value of Contrast-Enhanced Dual-Energy Computed Tomography in the Pancreatic Parenchymal and Delayed Phases for Pancreatic Cancer. Co-author DOI 10.3390/tomography10100117↗
  5. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasoun… Co-author DOI 10.1007/s00428-021-03236-w↗
  6. Covered metallic stent placement for biliary drainage could be promising in the coming era of neoadjuvant chemo-radiation therapy for all pancreatic cancer. First author DOI 10.1002/jhbp.958↗
  7. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review. Co-author DOI 10.1016/j.pan.2021.03.007↗
  8. Sarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherapy. Co-author DOI 10.1016/j.pan.2018.11.001↗
  9. Combined Analyses of hENT1, TS, and DPD Predict Outcomes of Borderline-resectable Pancreatic Cancer. Co-author DOI 10.21873/anticanres.11587↗
  10. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer. Co-author DOI 10.1245/s10434-012-2491-3↗
  11. Usefulness of endoscopic biopsy using FOXP3+ Treg up-regulation in the duodenal papilla in the differential diagnosis between autoimmune pancreatitis and pancr… Co-author DOI 10.1007/s00534-010-0359-0↗
  12. Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer. First author DOI 10.1111/j.1349-7006.2011.02053.x↗
  13. Covered stent placement for duodenal obstruction in pancreatic cancer. Co-author DOI 10.1159/000313695↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Itaru Endo · 8 shared papers, 2011–2026 · strength 1.00
  2. Noritoshi Kobayashi · 9 shared papers, 2011–2026 · strength 0.97
  3. Yusuke Kurita · 5 shared papers, 2019–2026 · strength 0.86
  4. Sho Hasegawa · 4 shared papers, 2021–2026 · strength 0.76
  5. Shin Yagi · 3 shared papers, 2021–2026 · strength 0.57
  6. Yasushi Ichikawa · 4 shared papers, 2013–2025 · strength 0.54
  7. Atsushi Nakajima · 2 shared papers, 2024–2026 · strength 0.43
  8. Atsushi Nakajima · 5 shared papers, 2011–2021 · strength 0.29
  9. Yasuhiro Yabushita · 2 shared papers, 2017–2025 · strength 0.29
  10. Satoshi Fujii · 1 shared paper, 2026 · strength 0.24
  11. Shin Maeda · 3 shared papers, 2011–2024 · strength 0.23
  12. Eriko Katsuta · 1 shared paper, 2025 · strength 0.22
  13. Ryutaro Mori · 1 shared paper, 2025 · strength 0.22
  14. Kentaro Miyake · 1 shared paper, 2025 · strength 0.22
  15. Itaru Naitoh · 2 shared papers, 2021–2022 · strength 0.21
  16. Tsukasa Ikeura · 2 shared papers, 2021–2022 · strength 0.21
  17. Terumi Kamisawa · 2 shared papers, 2021–2022 · strength 0.21
  18. Kazuichi Okazaki · 2 shared papers, 2021–2022 · strength 0.21
  19. Jun Ushio · 1 shared paper, 2025 · strength 0.20
  20. Yusuke Ishida · 1 shared paper, 2025 · strength 0.20
  21. Susumu Hijioka · 1 shared paper, 2025 · strength 0.20
  22. Daiki Yamashige · 1 shared paper, 2025 · strength 0.20
  23. Hirotoshi Ishiwatari · 1 shared paper, 2025 · strength 0.20
  24. Kotaro Takeshita · 1 shared paper, 2025 · strength 0.20
  25. Shota Harai · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.